BJCM
Blue Jay Capital Management Portfolio holdings
AUM
$147M
1-Year Return
64.18%
This Quarter Return
-8.1%
1 Year Return
+64.18%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$156M
AUM Growth
-$140M
(-47%)
Cap. Flow
-$132M
Cap. Flow
% of AUM
-84.59%
Top 10 Holdings %
Top 10 Hldgs %
75.5%
Holding
31
New
8
Increased
4
Reduced
4
Closed
15
Top Buys
| 1 |
MJN
Mead Johnson Nutrition Company
MJN
|
+$14.1M |
| 2 |
Ionis Pharmaceuticals
IONS
|
+$12.9M |
| 3 |
Integra LifeSciences
IART
|
+$12.1M |
| 4 |
ABMD
Abiomed Inc
ABMD
|
+$11.7M |
| 5 |
PDCO
Patterson Companies, Inc.
PDCO
|
+$6.64M |
Top Sells
| 1 |
Intuitive Surgical
ISRG
|
+$20.2M |
| 2 |
Edwards Lifesciences
EW
|
+$19.9M |
| 3 |
Biogen
BIIB
|
+$17.8M |
| 4 |
ENDP
Endo International plc
ENDP
|
+$15.6M |
| 5 |
BXLT
BAXALTA INC COM STK (DE)
BXLT
|
+$15M |
Sector Composition
| 1 | Healthcare | 84.17% |
| 2 | Consumer Staples | 9.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Bristol-Myers Squibb
BMY
$94B
| – | – |
-164,518
| Closed | -$11.3M |
|
|
27
Edwards Lifesciences
EW
$45.5B
| – | – |
-757,500
| Closed | -$19.9M |
|
28
Hologic
HOLX
$14.3B
| – | – |
-325,747
| Closed | -$12.6M |
|
|
29
Intuitive Surgical
ISRG
$161B
| – | – |
-333,000
| Closed | -$20.2M |
|
30
Perrigo
PRGO
$3.06B
| – | – |
-65,600
| Closed | -$9.49M |
|
31
Vertex Pharmaceuticals
VRTX
$101B
| – | – |
-80,020
| Closed | -$10.1M |
|